Trademark: 85036315
Status Date
Monday, July 22, 2013
Filing Date
Wednesday, May 12, 2010
Published for Opposition
Tuesday, October 12, 2010
Abandoned Date
Monday, July 22, 2013
5 Pharmaceutical preparations and substances for the prevention and treatment of migraine, infectious diseases, pain or inflammation, except pain or inflammation of the pancreas; Pharmaceutical preparations and substances for the prevention and treatment of oncological, musculoskeletal, cardiovascular, gastrointestinal, neurological, respiratory and immunologic system related diseases and disorders, except for gastrointestinal or respiratory diseases and disorders primarily attributed to pancreatic dysfunction
Jul 22, 2013
Abandonment Notice Mailed - No Use Statement Filed
Jul 22, 2013
Abandonment - No Use Statement Filed
Dec 18, 2012
Notice Of Approval Of Extension Request E-Mailed
Dec 17, 2012
Extension 3 Granted
Dec 13, 2012
Extension 3 Filed
Dec 13, 2012
Teas Extension Received
Jun 20, 2012
Notice Of Approval Of Extension Request E-Mailed
Jun 19, 2012
Extension 2 Granted
Jun 15, 2012
Extension 2 Filed
Jun 15, 2012
Teas Extension Received
Dec 21, 2011
Notice Of Approval Of Extension Request E-Mailed
Dec 20, 2011
Extension 1 Granted
Dec 6, 2011
Extension 1 Filed
Dec 20, 2011
Case Assigned To Intent To Use Paralegal
Dec 6, 2011
Teas Extension Received
Jun 21, 2011
Noa E-Mailed - Sou Required From Applicant
Apr 26, 2011
Extension Of Time To Oppose Process - Terminated
Apr 13, 2011
Changes/Corrections After Pub Approval Entered
Apr 8, 2011
Assigned To Petition Staff
Apr 7, 2011
Teas Post Publication Amendment Received
Nov 11, 2010
Extension Of Time To Oppose Received
Oct 12, 2010
Official Gazette Publication Confirmation E-Mailed
Oct 12, 2010
Published For Opposition
Sep 8, 2010
Law Office Publication Review Completed
Sep 8, 2010
Assigned To Lie
Aug 25, 2010
Approved For Pub - Principal Register
Aug 25, 2010
Assigned To Examiner
May 17, 2010
New Application Office Supplied Data Entered In Tram
May 15, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
